Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Antiphospholipid Syndrome”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Testing effectiveness (Phase 2)Looking for participantsNCT07584083
What this trial is testing

Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)

Who this might be right for
Antiphospholipid Syndrome (APS)
National and Kapodistrian University of Athens 20
Not applicableNot Yet RecruitingNCT06808607
What this trial is testing

Clinical Outcomes of Primary Versus Secondary Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid Syndrome
Assiut University 52
Testing effectiveness (Phase 2)Looking for participantsNCT06747312
What this trial is testing

Effect of Belimumab on Antibody Titers in Primary APS Patients

Who this might be right for
Antiphospholipid Syndrome (APS)
Ruijin Hospital 20
Not applicableStudy completedNCT04153201
What this trial is testing

Hydroxychloroquine for Thrombosis Prevention and Antiphospholipid Antibody Reduction in Primary Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid Syndrome
National and Kapodistrian University of Athens 50
Not applicableLooking for participantsNCT05786235
What this trial is testing

Patients Pregnant Women With or Without Primary Antiphospholipid Antibody Syndrome

Who this might be right for
PreeclampsiaImmunologic DiseaseAntiphospholipid Antibody Syndrome Primary+3 more
IRCCS San Raffaele 60
Not applicableUnknownNCT01956188
What this trial is testing

Omega 3 in LES and APS

Who this might be right for
Systemic Lupus ErythematosusPrimary Antiphospholipid Syndrome
University of Sao Paulo 22
Not applicableStudy completedNCT03941184
What this trial is testing

Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity

Who this might be right for
SCADAddison DiseaseAnkylosing Spondylitis+26 more
Mayo Clinic 114
Not applicableLooking for participantsNCT05904301
What this trial is testing

Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases

Who this might be right for
Behcet DiseaseAntineutrophil Cytoplasmic Antibody (ANCA) Positive VasculitisTakayasu Arteritis+6 more
Santé Arménie French-Armenian Research Center 800
Testing effectiveness (Phase 2)Looking for participantsNCT05671757
What this trial is testing

Daratumumab in Primary Antiphospholipid Syndrome

Who this might be right for
Autoimmune Disorders
National Institute of Allergy and Infectious Diseases (NIAID) 22
Testing effectiveness (Phase 2)Ended earlyNCT05078710
What this trial is testing

Telitacicept in Primary APS Patients

Who this might be right for
Anti Phospholipid Syndrome
Peking Union Medical College Hospital 20
Early research (Phase 1)Looking for participantsNCT07085676
What this trial is testing

Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases

Who this might be right for
Systemic Sclerosis (SSc)Idiopathic Inflammatory Myopathy (IIM)Rheumatoid Arthritis (RA)+6 more
Polina Stepensky 120
Not applicableNot Yet RecruitingNCT07251179
What this trial is testing

Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies

Who this might be right for
Systemic Lupus ErythematosusSystemic SclerodermaANCA-associated Vasculitis+2 more
University Hospital, Strasbourg, France 200
Testing effectiveness (Phase 2)WithdrawnNCT04275778
What this trial is testing

HYDROxychloroquine in Syndrome Primary AntiPhospholipid

Who this might be right for
Antiphospholipid Syndrome in PregnancyAnticoagulants
Assistance Publique - Hôpitaux de Paris
Not applicableStudy completedNCT03459508
What this trial is testing

Ocular Findings in Women With Primary Antiphospholipid Syndrome

Who this might be right for
Primary Antiphospholipid Syndrome
Cairo University 50
Large-scale testing (Phase 3)UnknownNCT03540810
What this trial is testing

Hydroxychloroquine Versus Placebo: Impact on Thrombotic Relapse in Primary Antiphospholipid Syndrome

Who this might be right for
Primary Antiphospholipid Syndrome
University Hospital, Angers 300
Not applicableLooking for participantsNCT06373926
What this trial is testing

Evaluation of Cell Membrane Expression of Annexin A2 on Monocytes by Flow Cytometry in Primary Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid Syndrome
Centre Hospitalier Universitaire, Amiens 60
Testing effectiveness (Phase 2)Study completedNCT06315530
What this trial is testing

Effect of Telitacicept on Antibody Titers in Primary APS Patients

Who this might be right for
Antiphospholipid Syndrome (APS)
Ruijin Hospital 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06504420
What this trial is testing

The Safety and Efficiency of Sirolimus in Primary Antiphospholipid Syndrome: a Randomized Control Study

Who this might be right for
Primary Antiphospholipid Syndrome
Peking University People's Hospital 70
Large-scale testing (Phase 3)Ended earlyNCT01784523
What this trial is testing

Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients

Who this might be right for
Antiphospholipid Syndrome
Hospital for Special Surgery, New York 11
Not applicableNot Yet RecruitingNCT07142239
What this trial is testing

Hematological Markers MPV, PLR, and NLR in Primary Versus Secondary Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid Syndrome
New Valley University 150